| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 10/17/2000 | US6133247 Method of detecting lung disease |
| 10/17/2000 | US6133198 Administering bioassimilable boron compounds to plants infected with viroids in an amount to provide in the plants a boron concentration of 100-150 ppm and protect them from the effect of subviral infections |
| 10/17/2000 | US6132768 Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors |
| 10/17/2000 | US6132767 Administering osmotic colonic evacuant containing a picosulfate |
| 10/17/2000 | US6132747 Compositions and methods for inhibiting nematocyst discharge |
| 10/17/2000 | US6132735 Reshaping of the cornea to reduce or eliminate refractive errors of the eye. |
| 10/17/2000 | US6132724 Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 10/17/2000 | US6132702 Oral care compositions comprising chlorite and methods |
| 10/17/2000 | US6132701 Aqueous solution containing calcium hydroxide. |
| 10/17/2000 | CA2009221C Spray preparations for respiratory tract infections |
| 10/15/2000 | CA2305825A1 Novel bioactivating substance |
| 10/11/2000 | EP1043023A1 Viscous compositions containing carbon dioxide |
| 10/11/2000 | EP1042312A1 PHOTOCHROMIC INDENO-FUSED NAPHTHO 2,1-b]PYRANS |
| 10/11/2000 | EP1041970A1 Compositions of microspheres for wound healing |
| 10/11/2000 | CN1269225A Nevus eliminating ointment |
| 10/11/2000 | CN1269214A Thrombus dissolving capsule |
| 10/11/2000 | CN1269212A Preparation of external-use Chinese medicine for chapped skin and chapped eczema |
| 10/11/2000 | CN1057228C Ointment for trauma and fracture and its preparation method thereof |
| 10/11/2000 | CN1057214C Cooling throat oral liquor and preparation technology |
| 10/11/2000 | CN1057212C Oral liquor for body-building |
| 10/11/2000 | CN1057211C Toxin-resolving plaster for curing carbuncle, furuncle etc. and preparation method |
| 10/11/2000 | CN1057207C Composition for treating osteoporosis |
| 10/10/2000 | US6130244 Product and method to reduce stress induced immune suppression |
| 10/10/2000 | US6129925 Container filled with infusion liquids and infusion preparation |
| 10/10/2000 | CA2183415C A new skin preparation composition |
| 10/10/2000 | CA2126648C Liposomes containing bioavailable iron (ii) and method for obtaining them |
| 10/10/2000 | CA2030516C Parathyroid hypertensive factor |
| 10/05/2000 | WO2000058321A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same |
| 10/05/2000 | WO2000057729A2 Beverages for treatment of glucose metabolism disorders |
| 10/05/2000 | WO2000057721A2 Edible solids for treatment of glucose metabolism disorders |
| 10/05/2000 | DE19914646A1 Combination of active agents for humans and animals, e.g. for medicinal, nutritional or cosmetic use, comprises a colostral milk product or extract, minerals and plant components or extracts |
| 10/05/2000 | CA2323140A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same |
| 10/04/2000 | EP1040833A1 Bone resorption suppressing agent |
| 10/04/2000 | EP1040819A2 Oral compositions comprising a potassium salt for reducing dental nerve and dentin sensitivity |
| 10/04/2000 | EP1039887A1 Methods for treatment of neuro- and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 10/04/2000 | EP0692959B1 Use of water-soluble magnesium salts and preparations for external application |
| 10/04/2000 | CN1268351A Female germicidal disinfectant contraceptive film |
| 10/04/2000 | CN1056999C Traditional Chinese medicine bolus for treating necrosis of head of femur |
| 10/04/2000 | CN1056994C External-use medicated ointment for treating necrosis of head of femur |
| 10/03/2000 | US6127428 Reducing the effects of right to left circulatory shunt comprising the steps of introducing into a blood vessel a therapeutically-effective amount of stabilized microbubbles, e.g. oxygen in a carrier such as a perfluorocarbon |
| 10/03/2000 | US6126966 Liposomes containing a cisplatin compound |
| 10/03/2000 | US6126832 Composition for dialysis and shock treatment |
| 10/03/2000 | CA2265921C Method of restoration of lactose tolerance in humans with the medical disorder of lactose intolerance |
| 09/28/2000 | WO2000057190A2 Prediction of diabetes impaired wound healing |
| 09/28/2000 | WO2000056743A1 Pharmaceutical compositions comprising metal complexes |
| 09/28/2000 | WO2000056327A1 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 09/28/2000 | WO2000056167A1 A method of preventing parturient hypocalcemia in animals and compositions used therein |
| 09/28/2000 | WO2000025726A3 Multilayer antibacterial treatment device |
| 09/28/2000 | WO2000013712A3 Methods and compositions for the prevention or treatment of cancer |
| 09/28/2000 | DE19912850A1 Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung Solution, in particular for hemodialysis or peritoneal dialysis, as well as processes for their preparation |
| 09/28/2000 | DE19911626A1 Use of amines or compounds that produce ammonium ions for treating inflammation, induce production of anti-inflammatory proteins |
| 09/28/2000 | CA2367282A1 Pharmaceutical compositions comprising metal complexes |
| 09/28/2000 | CA2366080A1 Prediction of diabetes impaired wound healing by urinary nitrate assay |
| 09/27/2000 | EP1038552A2 Solution, in particular a hemodialysis or peritoneal dialysis solution, and method for producing same |
| 09/27/2000 | EP1038524A1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof |
| 09/27/2000 | EP1037648A2 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 09/27/2000 | EP1037625A1 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 09/27/2000 | EP1037621A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 09/27/2000 | EP1037614A2 A double capsule for the administration of active principles in multiple therapies |
| 09/27/2000 | EP1037529A1 Composition useful for providing one-step surgical preparation and drape |
| 09/27/2000 | EP1005351A4 An aqueous metal bicarbonate solution and method of use |
| 09/27/2000 | CN1268058A The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 09/27/2000 | CN1267543A Quick-healing burn and scald treating medicine powder |
| 09/27/2000 | CN1267531A Preparation and use of external-use medicine for cardiac and cerebral vascular diseases and rheumatism |
| 09/27/2000 | CN1056773C Medical liquid for recovering cancer and tumour |
| 09/27/2000 | CN1056764C Medicated plaster for accelerating digestion |
| 09/27/2000 | CN1056751C Zhishiqingjie injecta |
| 09/21/2000 | WO2000054816A1 Method for the identification and removal of nits from hair |
| 09/21/2000 | WO2000054784A1 Complex comprising the coordination compound manganese, its medical effects and the mode of its production |
| 09/21/2000 | WO2000054593A1 Iodine preparation compositon |
| 09/21/2000 | WO2000026185A9 Omeprazole solution and method of using same |
| 09/21/2000 | WO2000025819A9 Enhanced radiation therapy |
| 09/21/2000 | WO2000006136A3 Therapeutic combination of polyamine with an anticancer agent |
| 09/21/2000 | DE19910986A1 Verwendung von Xenon bei der Behandlung von Neurointoxikationen Use of xenon in the treatment of Neurointoxikationen |
| 09/21/2000 | CA2360888A1 Method for the identification and removal of nits from hair |
| 09/20/2000 | EP1035857A1 Oral antioxidant preparation comprising selenium and reduced glutathione |
| 09/20/2000 | EP1035847A1 Stable solution of zinc and bicarbonate ions |
| 09/20/2000 | EP1035831A1 Use of carboxylic acid to stabilize or improve epidermal synthesized ceramide |
| 09/20/2000 | EP1024817A4 Method of curing aids with tetrasilver tetroxide molecular crystal devices |
| 09/20/2000 | CN1266703A Medicine for treating liver cancer and preparing process thereof |
| 09/20/2000 | CN1266700A Powdered bone-setting medicine |
| 09/20/2000 | CN1056531C Chinese medicine composition for treating skin disease |
| 09/20/2000 | CN1056524C Plaster for treating burn and scald and its preparation method |
| 09/20/2000 | CN1056518C Plaster for treatment of surgical diseases, e. g. cellulitis, tumor etc. |
| 09/20/2000 | CN1056514C Quick blood-forming agent |
| 09/20/2000 | CN1056512C Medicine for treatment of trigeminal neuralgia |
| 09/19/2000 | US6121263 Administering synergistic amount of a 1,2,4-benzotriazine-n-oxide derivative prior to administering taxol |
| 09/19/2000 | US6121254 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith |
| 09/19/2000 | US6121250 Emulsified liquid agent mainly consisting of water-soluble high-molecular weight compound and electrolyte contains silicone-containing antifoam agent |
| 09/19/2000 | US6121244 Antitumoral method by administration of partricin derivatives |
| 09/19/2000 | US6120785 Antimycotic ectoparasiticidal product-external use |
| 09/14/2000 | WO2000053541A1 A vital matter and a producing method |
| 09/14/2000 | WO2000053194A1 Remedies for joint diseases |
| 09/14/2000 | WO2000053193A1 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
| 09/14/2000 | WO2000053192A1 Use of xenon for treating neurointoxications |
| 09/14/2000 | WO2000053191A2 Modulation of skeletal muscle precursor cell activation |
| 09/14/2000 | CA2371927A1 Nitric oxide manipulation of muscle satellite cell activation |
| 09/13/2000 | EP1033996A1 Prevention and treatment of amyloidogenic disease |
| 09/13/2000 | EP1033984A1 Concentrate for medical solution and use thereof |
| 09/13/2000 | EP1033981A1 Formulations and methods for reducing toxicity of antineoplastic agents |